Regulation mechanism and targeting strategy of PDGFRA in GBM

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100047795

Enrollment

Unknown

Registered

2021-06-26

Start date

2021-08-01

Completion date

Unknown

Last updated

2022-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glioma

Interventions

Case series:None

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: More than 2 pathologists re-read the pictures together and confirmed the diagnosis as malignant glioma.

Exclusion criteria

Exclusion criteria: No.

Design outcomes

Secondary

Measure	Time frame
Expression of platelet derived factor AA;Tripartitemoti21;	—

Primary

Measure	Time frame
Expression of platelet—derived growth factor receptor alpha;Expression of Ephrin A2;	—

Countries

China

Contacts

Public ContactWang Yan

First Affiliated Hospital of Army Medical University, PLA

wang_yan1977@hotmail.com+86 18323126870

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026